Hezong Science&Technology Co., Ltd. (SHE:300477)
China · Delayed Price · Currency is CNY 2.730
-0.110 (-3.87%)
May 26, 2026, 3:05 PM CST
Hezong Science&Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,577 | 1,629 | 2,523 | 2,886 | 2,918 | 2,379 |
Other Revenue | 34.24 | 34.24 | 126.62 | 69.11 | 44.24 | 51.79 |
| 1,612 | 1,663 | 2,650 | 2,955 | 2,962 | 2,431 | |
Revenue Growth (YoY) | -29.56% | -37.24% | -10.33% | -0.23% | 21.86% | 87.03% |
Cost of Revenue | 1,647 | 1,683 | 2,537 | 2,748 | 2,332 | 1,858 |
Gross Profit | -35.16 | -20.33 | 113.3 | 207.02 | 629.73 | 572.62 |
Selling, General & Admin | 308.67 | 328.94 | 542.09 | 471.35 | 340.97 | 265.42 |
Research & Development | 71.73 | 77.13 | 113.1 | 116.09 | 97.86 | 74.95 |
Other Operating Expenses | 13.61 | 1.52 | -13.19 | 23.53 | 15.41 | 6.11 |
Operating Expenses | 406.97 | 409.15 | 633.03 | 628.58 | 481.56 | 385.35 |
Operating Income | -442.13 | -429.48 | -519.73 | -421.57 | 148.16 | 187.28 |
Interest Expense | -269.26 | -283.15 | -133.15 | -113.02 | -60.76 | -52.53 |
Interest & Investment Income | 31.02 | 30.12 | 16.87 | 10.7 | 4.96 | 6.71 |
Currency Exchange Gain (Loss) | 0.12 | 0.12 | -0.63 | 0.35 | -0.43 | 0.94 |
Other Non Operating Income (Expenses) | 5.62 | 6.27 | -277.77 | -3.48 | -7.69 | -6.18 |
EBT Excluding Unusual Items | -674.63 | -676.13 | -914.4 | -527.01 | 84.25 | 136.22 |
Impairment of Goodwill | -68.45 | -68.45 | -64.24 | -56.95 | - | - |
Gain (Loss) on Sale of Investments | 0 | - | -1.85 | -292.03 | -62.98 | -43.44 |
Gain (Loss) on Sale of Assets | -71.69 | -80.72 | -19.24 | -0.48 | -0.01 | -0.01 |
Asset Writedown | -239.85 | -242.93 | -116.76 | -5.31 | -1.54 | -0.47 |
Other Unusual Items | 9.19 | 9.19 | 9.92 | 0.18 | 12.28 | 13.82 |
Pretax Income | -1,045 | -1,059 | -1,107 | -881.59 | 32 | 106.11 |
Income Tax Expense | -56.16 | -55.25 | 219.11 | -43.49 | -0.99 | -0.36 |
Earnings From Continuing Operations | -989.27 | -1,004 | -1,326 | -838.1 | 32.99 | 106.48 |
Minority Interest in Earnings | 89.63 | 109.16 | 694.44 | 194.75 | -25.8 | -0.24 |
Net Income | -899.65 | -894.63 | -631.25 | -643.35 | 7.19 | 106.23 |
Net Income to Common | -899.65 | -894.63 | -631.25 | -643.35 | 7.19 | 106.23 |
Net Income Growth | - | - | - | - | -93.23% | - |
Shares Outstanding (Basic) | 1,072 | 1,072 | 1,070 | 1,072 | 719 | 966 |
Shares Outstanding (Diluted) | 1,072 | 1,072 | 1,070 | 1,072 | 719 | 966 |
Shares Change (YoY) | -0.47% | 0.20% | -0.22% | 49.07% | -25.52% | 18.26% |
EPS (Basic) | -0.84 | -0.83 | -0.59 | -0.60 | 0.01 | 0.11 |
EPS (Diluted) | -0.84 | -0.83 | -0.59 | -0.60 | 0.01 | 0.11 |
EPS Growth | - | - | - | - | -90.91% | - |
Free Cash Flow | 61.02 | 143 | 237.72 | -2,429 | -831.31 | -390.07 |
Free Cash Flow Per Share | 0.06 | 0.13 | 0.22 | -2.27 | -1.16 | -0.40 |
Gross Margin | -2.18% | -1.22% | 4.28% | 7.01% | 21.26% | 23.56% |
Operating Margin | -27.43% | -25.82% | -19.61% | -14.27% | 5.00% | 7.70% |
Profit Margin | -55.83% | -53.79% | -23.82% | -21.77% | 0.24% | 4.37% |
Free Cash Flow Margin | 3.79% | 8.60% | 8.97% | -82.21% | -28.07% | -16.05% |
EBITDA | -256.8 | -232.64 | -276.84 | -267.21 | 245.52 | 266.22 |
EBITDA Margin | -15.93% | -13.99% | -10.45% | -9.04% | 8.29% | 10.95% |
D&A For EBITDA | 185.33 | 196.84 | 242.88 | 154.36 | 97.36 | 78.94 |
EBIT | -442.13 | -429.48 | -519.73 | -421.57 | 148.16 | 187.28 |
EBIT Margin | -27.43% | -25.82% | -19.61% | -14.27% | 5.00% | 7.70% |
Revenue as Reported | 1,612 | 1,663 | 2,650 | 2,955 | 2,962 | 2,431 |
Advertising Expenses | - | 0.12 | 0.23 | 0.57 | 0.42 | 0.51 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.